Showing results (201-210 of 324) with videos related to

Sort By:
Pageof 33
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Neuropharmacology|February 1, 1997
Inhibition of neuronal high voltage-activated calcium channels by insect peptides: a comparison with the actions of omega-conotoxin GVIAR H Scott, V J Gorton, L Harding, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
CB 1954 revisited. II. Toxicity and antitumour activityP Workman, J E Morgan, K Talbot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1991
The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic studyN M Bleehen, T S Maughan, P Workman, et al.
British Journal of Cancer|August 1, 1995
The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysisE O Aboagye, A D Lewis, A Johnson, et al.
British Journal of Cancer|September 1, 1992
Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse dataT S Maughan, R Ward, I Dennis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 2000
Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinomaJ I Geh, R Glynne-Jones, Q S Kwok, et al.
ESMO Open|February 22, 2024
A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101)N Lakhani, R Cosman, U Banerji, et al.
British Journal of Cancer|November 20, 1998
Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694)I Judson, T Maughan, P Beale, et al.
British Journal of Cancer|April 3, 2003
A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)P Beale, I Judson, A O'Donnell, et al.
Pageof 33